Omission of adjuvant chemotherapy in patients with completely necrotic Wilms tumor stage I and radiotherapy in stage III: The 30‐year SIOP‐RTSG experience
Pediatric Blood & Cancer · 2024
DOI: 10.1002/pbc.30852 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Pediatric Blood & Cancer, 2024. Verfasst von Gordan M Vujanić und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Sidra Medicine, Doha, Qatar. Hauptthemen laut MEDLINE: Kidney Neoplasms, Wilms Tumor. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: Cancer Research UK.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Completely necrotic Wilms tumor (CN‐WT) following preoperative chemotherapy has been regarded as low‐risk WT since the International Society of Paediatric Oncology (SIOP) 93‐01 study, and patients have been treated with reduced postoperative therapy. The aim of the study was to evaluate whether the omission of adjuvant chemotherapy in patients with localized CN‐WT stage I and radiotherapy in stage III was safe. Patients and methods The retrospective observational study of outcomes of patients diagnosed with localized CN‐WT on central pathology review and treated according to the SIOP 93‐01 and SIOP‐WT‐2001 protocols (1993–2022).
Results
There were 125 patients with localized CN‐WT: 90 with stage I, 10 with stage II, and 25 with stage III. Sixty‐two of 125 (49.6%) patients had a discrepant diagnosis and/or staging between the institutional pathologist and central pathology review. In the group of 90 patients with stage I, postoperative chemotherapy was not given to 41 (46%) patients, whereas 49 patients received postoperative chemotherapy—in the latter group, two patients relapsed, and one of them died. One stage I and one stage II patient developed chemotherapy‐induced toxicity and died. Nineteen of 25 patients with stage III received no flank radiotherapy. No stage III patient relapsed or died. The overall 5‐year event‐free survival (EFS) estimate for the entire cohort (stages I–III) was 96.8% [95% confidence interval, CI: 93.6%–99.6%] and the overall survival (OS) was 97.6% [95% CI: 95.0–100%]. The EFS and OS were 97% and 98%, respectively, for stage I, and 100% for stage III.
Conclusion
Omission of postoperative chemotherapy for patients with CN‐WT stage I, and radiotherapy for stage III is safe. Rapid central pathology review is required to assign appropriate treatment and avoid treatment‐related side effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Sidra Medicine, Doha, Qatar.
- Weill Cornell Medicine - Qatar, Doha, Qatar.
- Department of Hematology and Oncology, Saarland University Hospital, Homburg, Germany.
- Department of Pathology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
- UCL Great Ormond Street Hospital Institute of Child Health, London, UK.
- Institut d'Hematologie et d'Oncologie Pédiatrique, Centre Léon Bérard, Lyon, France.
ORCID-Profile: Gordan M Vujanić, Norbert Graf, Ellen D'Hooghe, Kathy Pritchard-Jones, Christophe Bergeron, Harm van Tinteren, Rhoikos Furtwängler
Förderung
- Cancer Research UK
Zitieren
APA
Vujanić, G. M., Graf, N., D'Hooghe, E., Pritchard-Jones, K., Bergeron, C., Tinteren, H. V., Furtwängler, R., & International Society of Paediatric Oncology Renal Tumour Study Group (SIOP-RTSG) (2024). Omission of adjuvant chemotherapy in patients with completely necrotic Wilms tumor stage I and radiotherapy in stage III: The 30‐year SIOP‐RTSG experience. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.30852
Vancouver
Vujanić GM, Graf N, D'Hooghe E, Pritchard-Jones K, Bergeron C, Tinteren HV, et al. Omission of adjuvant chemotherapy in patients with completely necrotic Wilms tumor stage I and radiotherapy in stage III: The 30‐year SIOP‐RTSG experience. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.30852
BibTeX
@article{Vujani2024,
author = {Vujanić, Gordan M and Graf, Norbert and D'Hooghe, Ellen and Pritchard-Jones, Kathy and Bergeron, Christophe and Tinteren, Harm van and Furtwängler, Rhoikos and International Society of Paediatric Oncology Renal Tumour Study Group (SIOP-RTSG), International Society of Paediatric Oncology Renal Tumour Study Group (SIOP-RTSG)},
title = {Omission of adjuvant chemotherapy in patients with completely necrotic Wilms tumor stage I and radiotherapy in stage III: The 30‐year SIOP‐RTSG experience},
journal = {Pediatric Blood & Cancer},
year = {2024},
doi = {10.1002/pbc.30852}
}
EUVIMED